-
What to Expect When Diagnosed with ALK+ Lung Cancer
In this presentation, Upal Basu Roy, PhD, MPH, LUNGevity's executive director of research, speaks with Justin Gainor, MD, about what people with newly diagnosed ALK-positive lung... -
World Lung Cancer Day and the Changing Landscape of Lung Cancer
For decades, lung cancer was synonymous with low survival rates, limited treatment options, and poor quality of life for those living with the disease. Each year, more than 236,000... -
Lung Cancer Treatment Landscape: New Options and Ongoing Challenges
Drs. Upal Basu Roy, Amy Moore, and Dhru Deb discuss their recent publication in which they presented an analysis of the lung cancer drug pipeline. They talk about what it means for... -
Facebook Live: A Conversation with the EGFR Resisters Patient Group
Upal Basu Roy, PhD, MPH, LUNGevity's Executive Director of Research, chats with Jill Feldman and Ivy Elkins, co-founders of the EGFR Resisters; and Drs. Christine Lovly, MD, PhD... -
Newly Diagnosed with KRAS-Positive Lung Cancer?
LUNGevity's Amy Moore, PhD, sits down with Mark Awad, MD, PhD, a thoracic oncologist at Dana-Farber Cancer Institute, to discuss KRAS-positive lung cancer and what questions newly... -
Tips for Better Sleep
Sleep tips session with our sleep expert, Peggy Burhenn. -
University of Michigan ALK Positive Webinar
Amy Moore, PhD, LUNGevity's Vice President, Global Engagement and Patient Partnerships, conducts this webinar on ALK-positive lung cancer. -
Highlights of the 2022 AACR meeting
The American Association for Cancer Research (AACR) 2022 meeting was held in New Orleans from April 9 to 13. Doctors and researchers worldwide joined together virtually and in... -
Immunotherapy in Early-Stage Lung Cancer
Upal Basu Roy, PhD, MPH, LUNGevity's Executive Director of Research, interviews Patrick Forde, MD (MB, BCH), at the 2022 AACR meeting about his findings on immunotherapy in early...
Patient Gateway